IQWiG recommends changes to the chronic disease program to…

Photo of author
Written By Kampretz Bianca

Lorem ipsum dolor sit amet consectetur pulvinar ligula augue quis venenatis. 

/WavebreakMediaMicro, stock.adobe.com

Cologne – Many aspects of the Disease Management Program (DMP) for chronic back pain should or could be revised. A working group from the Institute for Quality and Efficiency in Healthcare (IQWiG) came to this conclusion after researching guidelines.

Chronic back pain is understood as pain below the costal arch and above the gluteal folds, with or without radiation and possible other complaints lasting more than three months.

Nonspecific back pain is much more common than specific back pain. Chronic non-specific low back pain is often multicausal in its genesis, so somatic, psychological and social factors must be taken into account in therapeutic planning.

On behalf of the Federal Joint Committee (G-BA), scientists examined the extent to which DMP regulations still correspond to the current state of medical science. To do this, they evaluated 425 recommendations from eleven current evidence-based guidelines. They found additional or different content in current guidelines for many aspects of care.

For example, guideline recommendations for diagnosis and examination of admission criteria for DMP have changed. Innovations also concern individually differentiated therapeutic planning, therapeutic measures with follow-up monitoring and cooperation between levels of care, as well as training for insured people.

Scientists have also identified additional aspects of care that have not yet been addressed in the DMP, such as combined treatment of physical therapy and psychotherapy, as well as digital medical applications. © hil/aerzteblatt.de

Source link

Leave a Comment

icId icId icId icId icId icId